🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
144,67 USD
Máx. histórico
156,45
70 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-7,53%
Rango 52 semanas
82,01 – 156,92
Variación hoy
-2,49%
Cierre anterior
148,36
Rango de hoy
143,47 – 147,62
Volumen hoy
8.862.415
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,42%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 146,13 (puede no estar actualizado)
- Dividend yield
- 2,29% (puede no estar actualizado)
- Precio objetivo analistas
- 160,29 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/08/1971 | 1,36 | 1,37 | 1,34 | 1,36 | +0,24% | 2,19% | 2.241.043 |
| 16/08/1971 | 1,35 | 1,37 | 1,35 | 1,36 | +2,75% | 1,47% | 3.440.794 |
| 13/08/1971 | 1,34 | 1,35 | 1,32 | 1,32 | -1,11% | 1,74% | 1.018.656 |
| 12/08/1971 | 1,33 | 1,34 | 1,33 | 1,34 | +0,38% | 0,62% | 1.139.386 |
| 11/08/1971 | 1,34 | 1,35 | 1,33 | 1,33 | -0,86% | 1,73% | 633.830 |
| 10/08/1971 | 1,33 | 1,34 | 1,32 | 1,34 | +0,87% | 1,61% | 996.019 |
| 09/08/1971 | 1,34 | 1,34 | 1,33 | 1,33 | -0,49% | 1,11% | 588.557 |
| 06/08/1971 | 1,36 | 1,37 | 1,33 | 1,34 | -1,35% | 2,81% | 837.562 |
| 05/08/1971 | 1,35 | 1,36 | 1,34 | 1,36 | +0,86% | 1,12% | 709.286 |
| 04/08/1971 | 1,35 | 1,35 | 1,34 | 1,35 | +0,00% | 0,74% | 1.712.851 |
| 03/08/1971 | 1,38 | 1,38 | 1,34 | 1,35 | -2,40% | 2,41% | 1.290.298 |
| 02/08/1971 | 1,37 | 1,38 | 1,37 | 1,38 | +1,22% | 0,97% | 1.275.206 |
| 30/07/1971 | 1,38 | 1,38 | 1,36 | 1,36 | -1,20% | 1,08% | 905.472 |
| 29/07/1971 | 1,38 | 1,39 | 1,38 | 1,38 | -0,48% | 0,60% | 445.190 |
| 28/07/1971 | 1,38 | 1,39 | 1,38 | 1,38 | +0,00% | 0,71% | 920.563 |
| 27/07/1971 | 1,39 | 1,39 | 1,38 | 1,38 | -0,60% | 0,72% | 709.286 |
| 26/07/1971 | 1,39 | 1,40 | 1,39 | 1,39 | +0,24% | 1,31% | 784.742 |
| 23/07/1971 | 1,38 | 1,39 | 1,38 | 1,39 | +0,36% | 0,72% | 822.470 |
| 22/07/1971 | 1,39 | 1,39 | 1,38 | 1,38 | -0,47% | 1,19% | 1.924.128 |
| 21/07/1971 | 1,38 | 1,39 | 1,38 | 1,39 | +1,33% | 1,20% | 1.448.755 |
| 20/07/1971 | 1,37 | 1,38 | 1,37 | 1,37 | +0,97% | 0,73% | 2.037.312 |
| 19/07/1971 | 1,36 | 1,37 | 1,36 | 1,36 | -0,24% | 0,97% | 897.926 |
| 16/07/1971 | 1,36 | 1,37 | 1,36 | 1,36 | +0,49% | 0,60% | 1.184.659 |
| 15/07/1971 | 1,35 | 1,37 | 1,35 | 1,36 | +0,37% | 0,98% | 1.984.493 |
| 14/07/1971 | 1,35 | 1,36 | 1,34 | 1,35 | +0,00% | 0,98% | 2.573.050 |
| 13/07/1971 | 1,35 | 1,35 | 1,35 | 1,35 | +0,37% | 0,49% | 399.917 |
| 12/07/1971 | 1,35 | 1,35 | 1,35 | 1,35 | -0,13% | 0,37% | 1.705.306 |
| 09/07/1971 | 1,35 | 1,35 | 1,35 | 1,35 | +0,25% | 0,36% | 656.467 |
| 08/07/1971 | 1,35 | 1,35 | 1,34 | 1,35 | +0,00% | 0,74% | 1.320.480 |
| 07/07/1971 | 1,33 | 1,35 | 1,33 | 1,35 | +2,14% | 1,00% | 2.112.768 |